Abstract:Background: Alpha-fetoprotein (AFP) has been extensively applied in clinical practice to detect and predict postoperative outcomes of patients with hepatocellular carcinoma (HCC). However, due to its low sensitivity and specificity, its efficacy has been questioned. Recently, novel serum biomarkers including Golgi protein 73 (GP73) and glypican-3 (GPC-3) have shown a better discriminatory ability than AFP in detecting early HCC. The results of the combined use of GP73, GPC-3 and APP in the diagnosis of HCC remain inconclusive. This investigation aimed to evaluate the discriminatory ability of GP73, GPC-3 and AFP to jointly identify HCC using the statistical methods of meta-analysis. Methods: Comprehensive database searches of Web of Science, the Cochrane Library, Embase, the Chinese Biomedical Literature Database, and the China National Knowledge Infrastructure were performed for literature dated up to 1 November, 2019. Studies relating to the diagnostic accuracy of the combination of GP73, GPC-3 and AFP in the identification of HCC were included. A random-effects model was used to pool sensitivity, specificity, the positive and negative likelihood ratios [positive likelihood ratio (PL.R) and negative likelihood ratio (NLR), respectively], and the diagnostic odds ratio (DOR). We applied the Fagan nomogram to assess the clinical utility of joint detection. The overall detection accuracy was determined using summary receiver operating characteristic curve (SROC) analysis. Meta-regression analysis of heterogeneity publication bias was analyzed with Stata (version 12.0). Results: Our meta-analysis focused on 12 studies involving 919 patients with HCC and 1,549 non-HCC patients. Sensitivity, specificity, PLR, NLR and DOR for joint detection, were 0.91 (95% CI: 0.87-0.94), 0.84 (95% CI: 0.77-0.89), 5.83 (95% CI: 4.05-8.40), 0.10 (95% CI: 0.07-0.15), 57.51 (95% CI: 35.92-92.08), respectively, when pooled, and the area under the SROC curve was 0.95. Conclusions: Current evidence indicates that GP73, GPC-3 and AFP exhibit much better accuracy for the diagnosis of HCC when used in combination rather than alone or in pairs.

Diagnostic Value of Aspartate Beta-Hydroxylase Combined with AFP and GP73 for Hepatocellular Carcinoma

Combined determination of serum DCP, GPC3 and HSP70 in diagnosis of AFP-negative primary liver carcinoma

Value of GPC3, GP73, AFP-L3 and AFP detection in the diagnosis of primary hepatic carcinoma

Use of combined detection of serum GP73 and IL-6 in diagnosis of primary hepatocellular carcinoma

Dignostic value of GP73 combined with AFP,GGT-II detection on primary liver cancer

Diagnostic value of Golgi protein 73 alone and in combination with alpha fetoprotein in hepatocellular carcinoma

Value and verification of combined tests of serum GP73,AFP-L3,GPC-3 and DCP in diagnosis of low concentration AFP of small primary hepatocellular carcinoma

Significance of combined test of serum GP73 and AFP-L3 in diagnosis of small primary hepatocellular carcinoma

Diagnostic value of Golgi-73 and AFP in primary hepatocelluar carcinoma with single assay or combined detection:a meta-analysis

Clinical Significance of Serum GP73,DCP,GPC-3 and AFP Tests in Diagnosis of Primary Hepatic Carcinoma

Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.

Clinical Value of Alpha-Fetoprotein Heterogeneity 3, Golgin 73 and Glypican 3 in Diagnosis of Primary Hepatic Cancer

Diagnostic value of serum AFP and AFU detection in primary hepatic carcinoma

A Meta-Analyses Diagnosis Value of Hepatocellular Cancer:Gp73 Combined with AFP Vs AFP

Values of Combined Detection of Serum ALP, GGT, 5'-NT and AFP in the Diagnosis of Primary Hepatic Carcinoma

Assessment of serum GP73, AFP-L3, AFP and AFU detection in the diagnosis of hepatocellular carcinoma

The Diagnostic Value of the Combination of Golgi Protein 73, Glypican-3 and Alpha-Fetoprotein in Hepatocellular Carcinoma: a Diagnostic Meta-Analysis.

Clinical Significance of Serum GP73, AFP, and CA199 Test in the Diagnosis of Hepatic Cancer

Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma

Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.

Diagnostic Value of Serum GP73 and AFP in Hepatocellular Carcinoma: a Meta-Analysis